Delia Goletti MD, PhD, is an Infectious Diseases specialist, responsible of the Translational Research Unit at the National Institute for Infectious Diseases in Rome, Italy. Her research focus is on TB immune pathogenesis, TB immunodiagnostic tests, biomarkers, autophagy, impact of Helminth infection on HIV and TB disease, impact of immune-suppressive therapy on infectious diseases. She has ongoing collaborations with several groups worldwide (India, Africa, Europe) working on the translational aspects of TB immune assays. She collaborates with the World Health Organization (WHO) and European Respiratory Society (ERS) for the project on TB elimination in low incidence countries. She collaborates with the New Diagnostics Working Group Task Force on Tests for progression of LTBI to active disease supported by WHO and FIND. She has a European patent (N. 1723426) on an assay of immune diagnosis of tuberculosis and on the monitoring of therapy efficacy of tuberculosis.